|
|
 |
- Molecular biology and biochemical aspects of heart failure
- Vascular biology, endothelial function
- Apoptosis in vascular and cardiac remodeling
- Genetic studies in cardiomyopathy
- Gene transfer therapy in heart failure
- Growth control and cytokines in vascular cells
- Natriuretic peptides in heart failure
- Endothelin in heart failure
- Pharmacologic modulation of vascular-endothelial function
- Neurohumoral, immunologic aspects of heart failure
- Inflammatory mediators and heart failure
- Diagnostic methods:
- Advances in echocardiography: contrast, TEE and 3D
- Nuclear cardiology - assessment of myocardial perfusion, function
and viability
- PET - new insights into myocardial metabolism
- Applications of cardiac magnetic resonance imaging
- Intracoronary flow, doppler measurements
- Heart failure due to coronary artery disease
- Mechanisms involved in myocardial stunning, hibernation and
preconditioning
- Acute myocardial infarction: thrombolysis and reperfusion
- Interventional cardiology in acute infarction and angina
- Antithrombotic and antiplatelet adjunctive therapy for PTCA
- Blockage of tissue proliferation after coronary interventions
- Left ventricular remodeling after myocardial infarction
- Secondary prevention of CAD, risk stratification
- Hypertension and heart failure, new therapeutic approaches
- Heart failure in women
- Dilated cardiomyopathy: various etiologies
- Ischemic cardiomyopathy
- Left ventricular hypertrophy
- Hypertrophic cardiomyopathy
- Role of the pericardium
- Heart failure in valvular heart disease
- Pulmonary circulation aspects, pulmonary hypertension
- Heart failure in systemic disease
- Heart failure in infancy and childhood
- Preventative aspects of heart failure
- Prognostic aspects of heart failure
- Predictors and markers of heart failure outcome
- Exercise physiology and rehabilitation in heart failure
- Nursing aspects of heart failure
- Epidemiology of heart failure
- Renal aspects - diuretics
- Digoxin and other new inotropic agents in heart failure
- ACE inhibitors and Angiotensin - II receptor blockers, Organic
nitrates - their role in heart failure management
- Beta-blockers and beta-adrenergic receptors in heart failure
- Calcium channel blockers and promoters in heart failure
- Results of major clinical trials
- Arrhythmias and antiarrhythmic drug therapy in heart failure
- Atrial flutter / fibrillation - electrophysiologic concepts
and clinical aspects
- Sudden death in heart failure
- Advances in internal defibrillation and implantable antiarrhythmic
devices
- Cardiac pacing strategies in heart failure
- Advances in congenital heart disease
- New approaches to surgical revascularization: minimally invasive
surgery, TMLR
- Therapeutic and physiologic issues surrounding heart valve surgery
- Mechanical support, left ventricular assist devices
- Recovery of myocyte in heart failure (role of assist device)
- Surgery for LV dysfunction
- Cardiac transplantation
- Practice guidelines, cost containment
 |
Cardiology
Online